About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 133 record(s)
Req # A-2022-001307
Seizure data, sourced from Seizure and Disposition reports, on illicit opioids broken down by number of seizures, volume, year, and province. Volumes of illicit fentanyl and derivatives seized broken down by province and year. Any data relating to…Organization: Health Canada
March 2023
Req # A-2022-001382
All documents listing the modalities of the Public Service Occupational Health Program (PSOHP) regarding correctional officers from the Correctional Service of Canada. The documents detailing the services offered by the Program, the conditions or…Organization: Health Canada
March 2023
Req # A-2022-001444
Extract of metadata from your Access to Information and Privacy (ATIP) case management system, Ricoh ATIP Application. A machine-readable Excel file of all access to information requests received since April 1, 2016 containing the following fields…Organization: Health Canada
March 2023
Req # A-2019-001917
Adverse Drug Reaction (ADR). Report number: E2B_02737965.Organization: Health Canada
March 2023
Req # A-2022-001311
Adverse Drug Reactions (ADRs) for REXULTI, ARIPIPRAZOLE. Report numbers: E2B_05795715, E2B_05717142, E2B_05720816. ADR for REXULTI. Report number: E2B_05723433. ADRs for ABILIFY MAINTENA, ARIPIPRAZOLE. Report numbers: E2B_05724504, E2B_05717118.Organization: Health Canada
March 2023
Req # A-2022-001406
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-110432-515, What We Heard Report During the 2022 Consultations on the Targeted Review of the Pest Control Products Act.Organization: Health Canada
March 2023
Req # A-2022-001434
Adverse Drug Reaction (ADR) for SOLIRIS. Report number: E2B_05935628.Organization: Health Canada
March 2023
Req # A-2021-000163
The internal lessons learned report conducted by the internal audit team at the Public Health Agency of Canada (PHAC), which focused on the agency’s communication with Canadians in the early days of the pandemic.Organization: Public Health Agency of Canada
March 2023
Req # A-2022-000294
The job description for the following roles: Designated Screening Officer, Screening Officer.Organization: Public Health Agency of Canada
March 2023
Req # A-2022-000347
The final copy of the internal lessons learned report conducted by the internal audit team at the Public Health Agency of Canada (PHAC), and completed in September 2022, which focused on the agency’s communication with Canadians in the early days of…Organization: Public Health Agency of Canada
March 2023